PROFILE: Tomas Salmonson, chair of the EMA's CHMP, on European collaboration, being a teenage lifeguard and Persian rugs
This article was originally published in SRA
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is the body that effectively says yes or no to your new drug in Europe. Since September 2012, the committee has been chaired by senior Swedish regulator Tomas Salmonson*. In this profile, by Francesca Bruce, find out what Dr Salmonson thinks of the pharmaceutical industry and what key advice he would give companies looking for regulatory approval… and also how he relaxes, what shaped him growing up and why he thinks his grandfather would be proud of him.